Abstract:Objective: The aim of this study was to investigate the mechanism to reverse the drug resistance of leukemia cells in Cyclosporine A(CsA), tetrandrine (Tet) alone or their combination by using empirical methods, and to provide the basic evidence for further study, and lay the theoretical basis for the clinical applications. Method: By MTT assay, the IC50(the concentration causing 50% inhibitor of cell growth) of DNR was determined;By flow cytomet ry (FCM) assay, the intracellular DNR concentration and the expression of P-glyco-protein (P-gp) were examined, and the apoptotic changes were observed by Anexin-V. By fluorescent semi-quantitative reverse transcriptase polymerase chain reaction (RT-PCR), the mRNA expression of multidrug resistance (MDR) was measured. Results: The IC50 of DNR for K562 and K562/A02 cells were 0.26mg/l and 21.22mg/l respectively. Treating K562/A02 cells with CsA(1mg/L), TTD(0.1mg/L)and both for 48 hours partially restored the sensitivity of K562/A02 cells to DNR(IC50 were 7.83 mg/L,5.32 mg/L,2.33 mg/L respectively.) but had not effect on K562 cells; K562/A02 cells showed apoptotic characteristics after treated with CsA, and both for 48 hours(Apoptosis rate was 10.27%,17.64%,52.79% respectively); The fluorescence intensity of intracellelar DNR in K562 and K562/A02 cells treated with DNR(1mg/L)was 522,173 respectively. CsA and TTD (alone or combination) elevated the intracellular DNR concentration in K562/A02 cells(the fluorescence intensity of intracellelar DNR in K562/A02 cells was 188,339,515 respectively); The fluorescence intensity of P-gp in K562 and K562/A02 cells was 0.5,97.97. The P-gp expression was down after treated with CsA, TTD and both(73.7,65.05,58.1); mdr1 mRNA was also down regulated, and the effect of their combination was greater. Date was analyzed by SPSS 13.0 software and expressed as mean ± SD. Conclusions: High expression of P-gp may be involved in the mechanism of multidrug resistance (MDR) of K562/A02 cells line; MDR can be partially reversed by CsA or TTD, of which the combination shows a great synergistic reversal effect.

A Bicistronic Retroviral Vector to Introduce Drug Resistance Genes into Human Umbilical Cord Blood CD34~+ Cells to Improve Combination Chemotherapy Tolerance

[Study on Expression and Resistance of the Double Drug Resistance Genes Transduced into Human Umbilical Cord Blood CD34+ Cells Mediated by Bicistronic Retroviral Vector].

[Improvement of Combination Chemotherapy Tolerance of Human Umbilical Cord Blood CD(34)(+) Cells Transducted with Double Drug Resistance Genes by a Bicistronic Retroviral Vector].

Genetic Modification of Hematopoietic Progenitor Cells for Combined Resistance to 4-Hydroperoxycyclophosphamide, Vincristine, and Daunorubicin.

[A Bicistronic Retroviral Vector Containing MGMT and MDR1 Drug Resistance Genes Transfer into Human Umbilical Cord Blood CD34+ Cells to Improve Combination Chemotherapy Tolerance].

Improvement of combination chemotherapy tolerance by introduction of polycistronic retroviral vector drug resistance genes MGMT and MDR1 into human umbilical cord blood CD34+ cells

[In Vitro Cotransfer Human Multidrug Resistance Gene (Mdr-1) and Dihydrofolate Reductase Gene (DHFR) into Human CD(34)(+) Progenitor Cells to Broaden the Spectrum of Drug Resistance].

Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene.

Mechanism underlying drug resistance of HepG2/ADM cells silently reversed by lentivirus-mediated BC047440 gene during chemotherapy

Preliminary Study of Retroviral Mediated Transfer of the Human Mdr-1 Gene into Murine and Human Hematopoietic Stem/progenitor Cells

[In Vitro Study on Transduction of Human O(6)-methylguanine-DNA-methyltransferase Cdna into Human Umbilical Cord Blood CD34(+) Cells].

Reversal of Multidrug Resistance by Magnetic Fe3o4 Nanoparticle Copolymerizating Daunorubicin and Mdr1 Shrna Expression Vector in Leukemia Cells

Retro viral mediated efficient transfer andexpression of multiple drug resistance gene to human leukemic cells

In Vitro Study of the Effect of Cyclosporine A, Tetrandrine and Their Combination on the Reversion of Multidrug Resistance in Leukemia Cell Line.

[Internal Ribosomal Entry Site-Mediated Expression of Human Multidrug Resistance 1 Gene in Human CD34(+) Cells]

Retroviral-mediated Transfer and Functional Expression of Multidrug Resistance Gene in Human Placenta Mesenchymal Stem Cells

Construction of multidrug resistance hepatocellular carcinoma cell model

[Reversal of Mdrl Gene-Dependent Multidrug Resistance in Multidrug Resistance Human Leukemia Cell Line K562/ADM Using Short Hairpin RNA Expression Vectors].

The transfection of multidrug resistance gene into mesenchymal stem cells derived from human bone marrow reinforcing the resistance to chemotherapy

Reversal of MDR1 Gene-Dependent Multidrug Resistance Using Short Hairpin RNA Expression Vectors

Expression of the Human Multidrug Resistance Gene Mdr1 in Leukemic Cells and Its Application in Studying P-glycoprotein Antagonists.